| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |